LENSAR, Inc. (LNSR)
NASDAQ: LNSR · Real-Time Price · USD
6.03
+0.01 (0.17%)
At close: Aug 11, 2026, 4:00 PM EDT
6.08
+0.05 (0.83%)
After-hours: Aug 11, 2026, 4:10 PM EDT
LENSAR Revenue
LENSAR had revenue of $13.43M in the quarter ending March 31, 2026, a decrease of -5.16%. This brings the company's revenue in the last twelve months to $57.70M, up 1.12% year-over-year. In the year 2025, LENSAR had annual revenue of $58.44M with 9.24% growth.
Revenue (ttm)
$57.70M
Revenue Growth
+1.12%
P/S Ratio
1.28
Revenue / Employee
$384,693
Employees
150
Market Cap
74.06M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 58.44M | 4.94M | 9.24% |
| Dec 31, 2024 | 53.49M | 11.33M | 26.87% |
| Dec 31, 2023 | 42.16M | 6.81M | 19.25% |
| Dec 31, 2022 | 35.36M | 899.00K | 2.61% |
| Dec 31, 2021 | 34.46M | 8.08M | 30.62% |
| Dec 31, 2020 | 26.38M | -4.15M | -13.58% |
| Dec 31, 2019 | 30.53M | 6.14M | 25.18% |
| Dec 31, 2018 | 24.39M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Xtant Medical Holdings | 121.91M |
| Outset Medical | 117.80M |
| Pulmonx | 87.44M |
| CVRx, Inc. | 61.19M |
| Myomo | 43.26M |
| electroCore | 36.97M |
| Rapid Micro Biosystems | 35.18M |
| Spectral AI | 16.93M |
LNSR News
- 7 days ago - LENSAR Transcript: AGM 2026 - Transcripts
- 7 weeks ago - LENSAR Proxy statement: Proxy filing - Filings
- 7 weeks ago - LENSAR Proxy statement: Proxy filing - Filings
- 3 months ago - LENSAR Earnings Call Transcript: Q1 2026 - Transcripts
- 3 months ago - LENSAR Earnings release: Q1 2026 - Filings
- 3 months ago - LENSAR Quarterly report: Q1 2026 - Filings
- 3 months ago - LENSAR® Reports First Quarter 2026 Results and Provides Business Update - GlobeNewsWire
- 3 months ago - LENSAR Slides: Corporate presentation - Filings